Page last updated: 2024-11-08

4-nitroquinoline-1-oxide and Glial Cell Tumors

4-nitroquinoline-1-oxide has been researched along with Glial Cell Tumors in 1 studies

4-nitroquinoline N-oxide : A quinoline N-oxide carrying a nitro substituent at position 4.

Research Excerpts

ExcerptRelevanceReference
" We show here that antisense suppression of WRN in two human glioma cell lines reproduces hallmarks of the drug cytotoxicity profile of WS cells, namely, hypersensitivity to 4-nitroquinoline 1-oxide, camptothecin and hydroxyurea."3.72The Werner syndrome protein confers resistance to the DNA lesions N3-methyladenine and O6-methylguanine: implications for WRN function. ( Blank, A; Bobola, MS; D Kolstoe, D; Gold, B; Loeb, LA; Meade, EH; Rabinovitch, PS; Silber, JR; Varadarajan, S, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blank, A1
Bobola, MS1
Gold, B1
Varadarajan, S1
D Kolstoe, D1
Meade, EH1
Rabinovitch, PS1
Loeb, LA1
Silber, JR1

Other Studies

1 other study available for 4-nitroquinoline-1-oxide and Glial Cell Tumors

ArticleYear
The Werner syndrome protein confers resistance to the DNA lesions N3-methyladenine and O6-methylguanine: implications for WRN function.
    DNA repair, 2004, Jun-03, Volume: 3, Issue:6

    Topics: 4-Nitroquinoline-1-oxide; Adenine; Alkylating Agents; Antineoplastic Agents; Apoptosis; Camptothecin

2004